Biodentine Versus White MTA Pulpotomy

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 4, 2011

Primary Completion Date

November 30, 2015

Study Completion Date

February 29, 2016

Conditions
Extensive Decay in Primary Molars
Interventions
DRUG

Biodentine pulpotomy

DRUG

White MTA pulpotomy

DRUG

Tempophore pulpotomy

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors
lead

University Ghent

OTHER

NCT01733420 - Biodentine Versus White MTA Pulpotomy | Biotech Hunter | Biotech Hunter